← FDA Drug Approvals (Drugs@FDA)

DOXORUBICIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALMAJECT · Approved 2012-11-08

Drug application

FDA Application #

ANDA065515

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXORUBICIN HYDROCHLORIDE

Generic name

Doxorubicin Hydrochloride

Active ingredients

DOXORUBICIN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ALMAJECT

First approval

2012-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown